287
Participants
Start Date
September 30, 2008
Primary Completion Date
March 31, 2010
Study Completion Date
May 31, 2010
armodafinil
150 mg/day armodafinil
placebo
placebo
armodafinil
200 mg/day armodafinil
armodafinil
250 mg/day armodafinil
Behavioral Medical Research of Staten Island, Staten Island
Behavioral Medical Research of Brooklyn, Brooklyn
Social Psychiatry Research Institute, Brooklyn
Finger Lakes Clinical Research, Rochester
Belmont Center for Comprehensive Treatment, Philadelphia
CRI Worldwide, Philadelphia
Keystone Clinical Studies LLC, Norristown
Clinical Insights, Glen Burnie
Sheppard Pratt Health System, Towson
Alliance Research Group, Richmond
Carolina Clinical Trials. Inc, Charleston
Carman Research, Smyrna
Atlanta Center for Medical Research, Atlanta
Comprehensive Neuroscience Inc, Atlanta
Scientific Clinical Research, Inc., Aventura
Fidelity Clinical Research, Lauderhill
Mental Health Advocates. Inc, Boca Raton
Collaborative NeuroScience Network, Torrance
Stedman Clinical Trials, LLC, Tampa
Midwest Clinical Research Center, Dayton
Uptown Research Institute. LLC, Chicago
St Louis Clinical Trials LC, St Louis
Via Christi Research, Wichita
Lake Charles Clinical Trials, Lake Charles
K and S Professional Research Services, LLC, Little Rock
University Hills Clinical Research, Irving
Community Clinical Research, Austin
FutureSearch Trials, Austin
CNRI Los Angeles LLC, Pico Rivera
Synergy Clinical Research Center, Escondido
Excell Research, Oceanside
CNRI-San Diego LLC, San Diego
Neuropsychiatric Research Center of Orange County, Santa Ana
Omega Clinical Trials, Anaheim
Collaborative NeuroScience, Garden Grove
Northwest Clinical Research Center, Bellevue
The Hospital of Central Connecticut, New Britain
Yale University School of Medicine, New Haven
CRI Worldwide LLC, Clementon
Lead Sponsor
Cephalon
INDUSTRY